A study team is preparing to initiate a Phase II trial for a novel colon cancer therapy. By signing the Form FDA 1572, the investigator is certifying that the investigator has:
Form FDA 1572 is the ''Statement of Investigator'' for IND studies.
21 CFR 312.53(c)(1)(vi)(b): Requires investigators to ''read and understand the Investigator's Brochure.''
By signing, the investigator also agrees to comply with regulations, maintain records, and supervise study conduct.
Other options (B--D) are not part of 1572 requirements.
Correct answer: A.
21 CFR 312.53(c)(1)(vi)(b).
Ilda
7 months agoMerri
7 months agoCaitlin
7 months agoGilma
7 months agoLuther
7 months agoHassie
8 months agoHassie
8 months agoKatlyn
8 months agoTegan
8 months agoShonda
9 months agoRima
9 months agoJulian
9 months agoAilene
9 months agoHuey
9 months ago